The fibroblast growth factor (FGF) family play critical regulatory roles in development, metabolism and tissue homeostasis and their therapeutic applications are being widely explored. This Review highlights recent advances in understanding of FGF signalling, discusses the current status of endocrine FGF-based drug development and assesses the emerging potential of harnessing paracrine FGFs in the treatment of metabolic diseases.
- Gaozhi Chen
- Lingfeng Chen
- Moosa Mohammadi